1-3 of 3
Patrick Bruck
Close
Sort by
Journal Articles

Risk Factors for Infectious Complications in Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Patrick Bruck, Thomas Parnavas, Dieter Hoelzer, MD, PhD, Hubert Serve, Oliver G. Ottmann, MD, Angelika Boehme
Journal: Blood
Blood (2008) 112 (11): 4043.
https://doi.org/10.1182/blood.V112.11.4043.4043
Published: 2008
Journal Articles

Multicenter Phase II Trial of Patients with Refractory or Recurrent Multiple Myeloma with Oral Treatment of Thalidomide Combined with Oral Cyclophosphamide, Idarubicin and Dexamethasone.

Axel Glasmacher, MD, Thomas Moehler, MD, Hartmut Goldschmidt, MD, Thomas Geer, MD, Rolf Kleinschmidt, MD, Tobias Gaska, MD, Janssens Uwe, MD, Jorg Schubert, MD, Patrick Bruck, MD, Michael R. Clemens, MD, Wolfgang Bair, MD, Gernot Seipelt, MD, Michael Schleuning, MD, Corinna Hahn-Ast, PhD, Susanne Herz, Marie von Lilienfeld-Toal, MD, Ralf Naumann, MD, Marcus Gorschluter, MD, Ingo G.H. Schmidt-Wolf, MD
Journal: Blood
Blood (2007) 110 (11): 4825.
https://doi.org/10.1182/blood.V110.11.4825.4825
Published: 2007
Journal Articles

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL)

Heike Pfeifer, Barbara Wassmann, Anna Pavlova, Lydia Wunderle, Johannes Oldenburg, Anja Binckebanck, Thoralf Lange, Andreas Hochhaus, Silvia Wystub, Patrick Brück, Dieter Hoelzer, Oliver G. Ottmann
Journal: Blood
Blood (2007) 110 (2): 727–734.
https://doi.org/10.1182/blood-2006-11-052373
Published: 2007